Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2013

01-11-2013 | Poster presentation

PB.48: Old habits die hard: breast imaging of symptomatic 35 to 39 year olds

Authors: FM Singh, S Gadde

Published in: Breast Cancer Research | Special Issue 1/2013

Login to get access

Excerpt

The Best Practice Diagnostic Guidelines for Patients Presenting with Breast Symptoms were published in 2010 and suggest patients younger than 40 years should undergo breast ultrasound (US) as first-line imaging, with additional mammography for indeterminate and suspicious clinical or US findings. However, our current departmental guidelines are to use first-line mammography in patients aged 35 and over. The aims were to quantify the use of imaging modalities and cancer detection; to assess whether additional information gained by mammography changed management; and to quantify how many fewer mammograms would have been performed if we had adhered to the 2010 Guidelines. …
Metadata
Title
PB.48: Old habits die hard: breast imaging of symptomatic 35 to 39 year olds
Authors
FM Singh
S Gadde
Publication date
01-11-2013
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2013
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3548

Other articles of this Special Issue 1/2013

Breast Cancer Research 1/2013 Go to the issue

Poster presentation

PB.03: Evaluating the role of breast MRI at mid-cycle chemotherapy

Poster presentation

PB.05: MRI-guided vacuum-assisted breast biopsy at 3T: initial experience

Poster presentation

PB.18: Factors affecting breast density assessment

Poster presentation

PB.39: Minimising the impact of breast screening extension: a 1-year experience of a South West breast screening unit

Poster presentation

PB.24: Is digital breast tomosynthesis helpful within a symptomatic one-stop breast clinic for characterisation of subtle findings?

Poster presentation

PB.20: Accuracy of specimen radiograph in determining lesion presence in excised specimens, correlating histological and radiological margins
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits